Leukosite's IPO

Leukosite raised a round of funding on August 15, 1997. Investors include Public.

Leukosite develops drugs to block disease promoting actions of white blood cells, with potential applications within the areas of cancer, autoimmune and viral diseases.…

Articles about Leukosite's IPO: